Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000812806 | SCV000953131 | likely pathogenic | Hypohidrotic X-linked ectodermal dysplasia | 2020-08-03 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the p.Tyr61 amino acid residue in EDA have been observed in affected individuals (PMID: 8696334). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has been observed in an individual affected with ectodermal dysplasia (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with asparagine at codon 61 of the EDA protein (p.Tyr61Asn). The tyrosine residue is moderately conserved and there is a large physicochemical difference between tyrosine and asparagine. |